SMYD3 assumes a crucial role in tumorigenesis [25], as evidenced by its consistently elevated expression during the initiation and progression of various tumor types, including colorectal cancer, hepatocellular cancer, breast cancer, and ovarian cancer [26–28]. Here, SMYD3 is linked to breast cancer.